The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
Abstract
The drug sensitivities of human immunodeficiency virus (HIV) isolates from a group of patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) who were receiving zidovudine (3′-azido-3′-deoythymidine, AZT) therapy were tested by means of a newly developed plaque assay in CD4 + HeLa cells. Fifty percent inhibitory dose (ID 50 ) values of 18 isolates from untreated individuals ranged between 0.01 μ M and 0.05 μ M . In contrast, most isolates from patients who had received zidovudine for 6 months or more exhibited decreased sensitivity characterized by changes in ID 50 or ID 95 values (or both), with isolates from several patients (5/15) showing 100-fold increases in ID 50 . The latter isolates were also insensitive to 3′-azido-2′,3′-dideoxyuridine; however, the isolates were still sensitive to 2′,3′-dideoxycytidine, 2′,3′-dideoxy-2′,3′-didehydrothymidine, or phosphonoformate. It cannot be determined from this small sample of patients whether development of a less sensitive virus phenotype results in clinical resistance. Appearance of such variants was not associated with a consistent increase in viral p24 concentrations in patient plasma and did not herald any sudden deterioration in clinical status. More extensive studies are required to determine the clinical significance. Thus, it would be premature to alter any treatment protocols for HIV-infected individuals at present.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a clinical trial, its dramatic short-term effects in delaying the death of AIDS patients (109) led to its rapid approval for use, although the virus rebounded after a few months due to the appearance of mutations in RT that render it AZT resistant (110).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [110]
Citations
Cites
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170401 · Cited by 2,995
Self-citationThe Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
Richman, D. D., Fischl, M. A., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Hirsch, M. S., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170402 · Cited by 1,199
Self-citationInfection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque Assay
Harada, S., Koyanagi, Y., & Yamamoto, N. (1985) · Science · doi:10.1126/science.2992081 · Cited by 857
Schmitt, F. A., Bigley, J. W., McKinnis, R., Logue, P. E., Evans, R. W., Drucker, J. L., & The AZT Collaborative Working Group* (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192404 · Cited by 396
Klecker, R. W., Collins, J. M., Yarchoan, R., Thomas, R., Jenkins, J. F., Broder, S., & Myers, C. E. (1987) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1987.49 · Cited by 381
Site-specific mutagenesis of AIDS virus reverse transcriptase
Larder, B. A., Purifoy, D. J. M., Powell, K. L., & Darby, G. (1987) · Nature · doi:10.1038/327716a0 · Cited by 312
Self-citationDevelopment of a sensitive quantitative focal assay for human immunodeficiency virus infectivity
Chesebro, B., & Wehrly, K. (1988) · Journal of Virology · doi:10.1128/jvi.62.10.3779-3788.1988 · Cited by 304
Field, H. J., & Darby, G. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.17.2.209 · Cited by 242
Self-citationISOLATION AND CHARACTERISATION OF RESISTANT HERPES SIMPLEX VIRUS AFTER ACYCLOVIR THERAPY
Burns, W., Santos, G., Saral, R., Laskin, O., Lietman, P., Mclaren, C., & Barry, D. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91620-8 · Cited by 240
Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance
Darby, G., Field, H. J., & Salisbury, S. A. (1981) · Nature · doi:10.1038/289081a0 · Cited by 204
Self-citation
Cited by
Items 901–1,000 of 1,000
In vitro selection of human immunodeficiency virus type 1 resistant to 3′-azido-3′-deoxythymidine
DIANZANI, F., Antonelli, G., Turriziani, O., Dong, G., Capobianchi, M. R., & Riva, E. (1992) · Antiviral Research · doi:10.1016/0166-3542(92)90004-o · Cited by 16
Characterization of HIV Reverse Transcriptases with Tyr181→Cys and Leu100→lle Mutations
Zhang, H., Vrang, L., Unge, T., & Öberg, B. (1993) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029300400506 · Cited by 16
Zidovudine for symptomless HIV infection
(1990) · The Lancet · doi:10.1016/0140-6736(90)90938-2 · Cited by 16
Kisic, M., Matamoros, T., Nevot, M., Mendieta, J., Martínez‐Picado, J., Martínez, M. Á., & Menéndez‐Arias, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.226100 · Cited by 15
Huigen, M. C. D. G., van Ham, P. M., de Graaf, L., Kagan, R. M., Boucher, C. A., & Nijhuis, M. (2008) · Retrovirology · doi:10.1186/1742-4690-5-20 · Cited by 15
Curr, K. A., Tripathi, S., Lennerstrand, J., Larder, B. A., & Prasad, V. R. (2006) · Journal of General Virology · doi:10.1099/vir.0.81458-0 · Cited by 15
Self-citationWright, D. W., Deuzing, I. P., Flandre, P., den Eede, P. V., Govaert, M., Setiawan, L. C., Coveney, P. V., Marcelin, A., Cálvez, V., Boucher, C. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074078 · Cited by 15
In vitroantiviral activities of extracts derived fromDaucus maritimusseeds
Miladi, S., Abid, N., Debarnot, C., Mohamed Damak, A., Canard, B., Aouni, M., & Selmi, B. (2011) · Natural Product Research · doi:10.1080/14786419.2010.550263 · Cited by 15
Oguariri, R. M., Dai, L., Adelsberger, J. W., Rupert, A. W., Stevens, R. A., Yang, J., Huang, D.-W., Lempicki, R. A., Zhou, M., Baseler, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.468975 · Cited by 15
Ibe, S., Hattori, J., Fujisaki, S., Shigemi, U., Fujisaki, S., Shimizu, K., Nakamura, K., Kazumi, T., Yokomaku, Y., Mamiya, N., et al. (2008) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2007.0129 · Cited by 15
Epidemiological aspects of transmitted HIV drug resistance
Girardi, E. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/03008870310009597 · Cited by 15
Winters, M. A., Holodniy, M., Katzenstein, D. A., & Merigan, T. C. (1992) · Genome Research · doi:10.1101/gr.1.4.257 · Cited by 15
Assessment of Anti‐HIV Activity of Some Benzimidazolylthiazoles
BADAWEY, E. ‐. A. M., Hazzaa, A. A., Rida, S. M., & Fahmy, H. T. Y. (1992) · Archiv der Pharmazie · doi:10.1002/ardp.19923250908 · Cited by 15
Hitchcock, M. J. M. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/16.supplement_1.s16 · Cited by 15
Tanabe-Tochikura, A., Nakashima, H., Murakami, T., Tenmyo, O., Oki, T., & Yamamoto, N. (1992) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029200300604 · Cited by 15
Antiviral activities of nucleotide heterodimers against human immunodeficiency virus type 1 in vitro
Ijichi, K., Fujiwara, M., Mori, K., MOROZUMI, M., Machida, H., Shigeta, S., Konno, K., Yokota, T., & Baba, M. (1996) · Antiviral Research · doi:10.1016/0166-3542(96)00945-x · Cited by 15
Ramezani, A., Ma, X. Z., Nazari, R., & Joshi, S. (2002) · Frontiers in bioscience · doi:10.2741/ramezani · Cited by 15
Gallo, J. M., Sanzgiri, Y. D., Howerth, E. W., Finco, T. S., Wilson, J., Johnston, J., Tackett, R. L., & Budsberg, S. C. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810103 · Cited by 15
Renault, J., LADUREE, D., & Robba, M. (1994) · Nucleosides and Nucleotides · doi:10.1080/15257779408011884 · Cited by 15
Beltangady, M. S., Knupp, C. A., Gustafson, N., Barbhaiya, R. H., Dolin, R., Seidlin, M., Cooley, T. P., & Rozencweig, M. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/16.supplement_1.s26 · Cited by 15
The epidemiology of HIV infection and AIDS
Daykin, C. D. (1990) · Journal of the Institute of Actuaries · doi:10.1017/s002026810004302x · Cited by 15
Zazzi, M., Catucci, M., Milito, A. D., Romanó, L., Venturi, G., Valensin, P. E., Almi, P., Gonnelli, A., & Rubino, M. (1996) · Infection · doi:10.1007/bf01713041 · Cited by 15
Biology of retroviruses: Detection, molecular biology, and treatment of retroviral infection
Wells, K. H., & Poiesz, B. J. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70161-a · Cited by 15
McElrath, M. J., Rabin, M., Hoffman, M., Klucking, S., Garcia, J. V., & Greenberg, P. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.5074-5083.1994 · Cited by 15
Balfour, H. H., & Englund, J. A. (1989) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1989.02150230065025 · Cited by 15
Tachedjian, G., Tyssen, D. P., LOCARNINI, S. A., Gust, I. D., & Birch, C. (1990) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029000100208 · Cited by 15
Mohan, P., Hopfinger, A. J., & Baba, M. (1991) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029100200402 · Cited by 15
Connell, E. V., Hsu, M. C., & Richman, D. D. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.348 · Cited by 15
Self-citationVaerenbergh, K. V., Laethem, K. V., Wijngaerden, E. V., Schmit, J., Schneider, F., Ruiz, L., Clotet, B., Verhofstede, C., Wanzeele, F. V., Uyldermans, G. M., et al. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/088922200308945 · Cited by 15
2′,3′-Dideoxycytidine induced drug resistance in human cells
Magnani, M., Gazzanelli, G., Brandi, G., Casablanca, A., Fraternale, A., Chiarantini, L., & Rossi, L. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02021-a · Cited by 15
AIDS and the gastroenterologist
Smallwood, R. A. (1990) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1990.tb01781.x · Cited by 15
Anti-HIV Antiviral Activity of Stavudine in a Thymidine Kinase-Deficient Cellular Line
Turriziani, O., Simeoni, E., DIANZANI, F., & Antonelli, G. (1998) · Antiviral Therapy · doi:10.1177/135965359800300310 · Cited by 15
New isomeric analogues of anti-HIV active azidonucleosides
Jeon, G. S., & Nair, V. (1996) · Tetrahedron · doi:10.1016/0040-4020(96)00766-1 · Cited by 15
Bertrand, É., & Rossi, J. J. (1996) · Nucleic acids and molecular biology · doi:10.1007/978-3-642-61202-2_17 · Cited by 15
Cellular Targets of HIV-1 Protease: Just the Tip of the Iceberg?
Centazzo, M., Manganaro, L., & Alvisi, G. (2023) · Viruses · doi:10.3390/v15030712 · Cited by 14
Enzyme Inhibition and Inactivation
Silverman, R. B., Xue, F., & Juncosa, J. I. (2004) · Elsevier eBooks · doi:10.1016/b978-0-08-051337-9.50010-9 · Cited by 14
A Direct Brønsted Acid‐Catalyzed Azidation of Benzhydrols and Carbohydrates
Regier, J., Maillet, R., & Bolshan, Y. (2019) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201900104 · Cited by 14
Randall, C. L., Burkard, M. E., & Jallepalli, P. V. (2007) · Cell Cycle · doi:10.4161/cc.6.14.4501 · Cited by 14
Oh, Y., & Cho, S. (1998) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.5570350104 · Cited by 14
Virologic Risk Factors for Vertical Transmission of HIV Type 1 in Puerto Rico
Arroyo, M. A., Tien, H.-C., Pagán, M., Swanstrom, R. I., Hillyer, G. V., Cadilla, C. L., & Melendez-Guerrero, L. M. (2002) · AIDS Research and Human Retroviruses · doi:10.1089/088922202753614218 · Cited by 14
Mother-to-child transmission of drug-resistant HIV
Kijak, G. H., Ávila, M. M., & Salomón, H. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0182 · Cited by 14
Menzo, S., Rusconi, S., Monachetti, A., Colombo, M. C., Violin, M., Bagnarelli, P., Varaldo, P. E., Moroni, M., Galli, M., Balotta, C., et al. (2000) · AIDS · doi:10.1097/00002030-200006160-00006 · Cited by 14
Matthews, S. J., Cersosimo, R. J., & Spivack, M. L. (1991) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1991.tb02658.x · Cited by 14
Recombinant Human Interferon-β Suppresses the Replication of HIV and Acts Synergistically with AZT
Williams, G. J., & Colby, C. (1989) · Journal of Interferon Research · doi:10.1089/jir.1989.9.709 · Cited by 14
Bush, C. E., Donovan, R. M., Smereck, S. M., STRANG, D., Markowitz, N. P., & Saravolatz, L. D. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.183 · Cited by 14
Clark, T. N., White, C. A., Chu, C. K., & Bartlett, M. G. (2001) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(01)00054-8 · Cited by 14
Nielsen, C., Gøtzsche, P. C., Nielsen, C. M., Gerstoft, J., & Vestergaard, B. F. (1992) · Antiviral Research · doi:10.1016/0166-3542(92)90063-b · Cited by 14
Kessler, H. A., Bick, J. A., Pottage, J. C., & Benson, C. A. (1992) · Disease-a-Month · doi:10.1016/0011-5029(92)90027-m · Cited by 14
Billich, A., Fricker, G., Müller, I. C., Donatsch, P., Ettmayer, P., Gstach, H., Lehr, P., Peichl, P., Scholz, D., & Rosenwirth, B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.7.1406 · Cited by 14
Im, G., Tramontano, E., Gonzalez, C. J., & Cheng, Y.-C. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90622-4 · Cited by 14
The 5′-Hydrogen Phosphonate Analog as a Potential Prodrug of 3′-Azido-2′,3′-dideoxythymidine (AZT)
Boal, J. H., Iyer, R. P., & Egan, W. (1993) · Nucleosides and Nucleotides · doi:10.1080/07328319308016205 · Cited by 14
Pal, R., Mumbauer, S. W., Hoke, G., LaRocca, R. V., Myers, C. E., Sarngadharan, M. G., & Stein, C. A. (1991) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1991.7.537 · Cited by 14
Blackbourn, D. J., Chuang, L. F., Sutjipto, S., Killam, K. F., McCready, P., Doi, R. H., Li, Y., & Chuang, R. Y. (1992) · Journal of Virological Methods · doi:10.1016/0166-0934(92)90038-f · Cited by 14
Antiviral properties of aminodiol inhibitors against human immunodeficiency virus and protease
Bechtold, C. M., Patick, A. K., Alam, M., Greytok, J. A., Tino, J. A., Chen, P., Gordon, E. M., Ahmad, S., Barrish, J. C., & Zahler, R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.374 · Cited by 14
Screening of Compounds for Activity against HIV: A Collaborative Study
Holmes, H. C., Mahmood, N., Karpas, A., Petrík, J., Kinchington, D., O'Connor, T., Jeffries, D. J., Desmyter, J., Clercq, E. D., Pauwels, R., et al. (1991) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029100200503 · Cited by 14
Current Insights into Reverse Transcriptase Inhibitor-Associated Resistance
Wainberg, M. A., & White, A. J. (2001) · Antiviral Therapy · doi:10.1177/135965350100602s02 · Cited by 14
Vaccination with CTL epitopes that escape: an alternative approach to HIV vaccine development?
O’Connor, D. H., Allen, T. M., & Watkins, D. I. (2001) · Immunology Letters · doi:10.1016/s0165-2478(01)00268-1 · Cited by 14
Treatment of HIV Infection — Progress in Perspective
Corey, L., & Fleming, T. R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202133260710 · Cited by 14
Zidovudine susceptibility testing of human immunodeficiency virus type 1 (HIV) clinical isolates
Shafer, R. W., Kozal, M. J., Katzenstein, D. A., Lipil, W. H., Johnstone, I. M., & Merigan, T. C. (1993) · Journal of Virological Methods · doi:10.1016/0166-0934(93)90019-n · Cited by 14
Recombinant retroviral systems for the analysis of drug resistant HIV
STRAIR, R. K., Median, D. J., Nelson-Williams, C. J., Graubert, T. A., & Mellors, J. W. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.20.4836 · Cited by 14
Anti-HIV-1 Antibodies: An Update
Promsote, W., DeMouth, M. E., Almasri, C. G., & Pegu, A. (2020) · BioDrugs · doi:10.1007/s40259-020-00413-2 · Cited by 13
Increase in CD4 Lymphocyte Counts After Splenectomy in HIV-infected Patients
Tunkel, A. R., Kelsall, B. L., Rein, M. F., Innes, D. J., Saulsbury, F. T., Vollmer, K., & Wispelwey, B. (1993) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199308000-00009 · Cited by 13
van Leeuwen, R., van den Hurk, P. J., Jöbsis, G. J., van der Wouw, P. A., Reiss, P., Schattenkerk, J. K. M. E., Danner, S. A., & Lange, J. M. A. (1990) · Sexually Transmitted Infections · doi:10.1136/sti.66.6.418 · Cited by 13
Meeting report: 29th International Conference on Antiviral Research in La Jolla, CA, USA
Hodge, R. A. V. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.10.014 · Cited by 13
Garriga, C., & Menéndez‐Arias, L. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-44 · Cited by 13
Eggink, D., Huigen, M. C. D. G., Boucher, C. A., Götte, M., & Nijhuis, M. (2007) · Antiviral Research · doi:10.1016/j.antiviral.2007.03.001 · Cited by 13
Tripathi, S., Maity, J., Achari, B., & Mandal, S. B. (2005) · Carbohydrate Research · doi:10.1016/j.carres.2005.02.007 · Cited by 13
Kaul, N., Agrawal, H., Paradkar, A. R., & Mahadik, K. R. (2004) · Chromatographia · doi:10.1365/s10337-004-0367-9 · Cited by 13
SYNTHESIS OF CERTAIN 6-(ARYLTHIO)URACILS AS POTENTIAL ANTIVIRAL AGENTS
El-Emam, A. A.-R., Nasr, M. N. A., Pedersen, E. B., Fouad, T., & Nielsen, C. (2001) · Phosphorus, sulfur, and silicon and the related elements · doi:10.1080/10426500108040231 · Cited by 13
Oh, Y., Lee, C., Chung, Y., Yoon, S., & Cho, S. H. (1998) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.5570350309 · Cited by 13
Caufield, W. V., & Stewart, J. T. (2002) · Journal of Liquid Chromatography & Related Technologies · doi:10.1081/jlc-120005874 · Cited by 13
Zeichner, S. L. (1994) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30361-0 · Cited by 13
Quinobene, a new potent anti-HIV agent
Gruszecka‐Kowalik, E., Haugwitz, R. D., & Zalkow, L. H. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90459-x · Cited by 13
Playing chess with reverse transcriptase
Richman, D. D. (1993) · Nature · doi:10.1038/361588a0 · Cited by 13
Self-citationChemotherapy of feline immunodeficiency virus infection
Egberink, H. F., Hartman, K. P., & Horzinek, M. C. (1991) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.1991.199.10.1485 · Cited by 13
Pharmacokinetics of 2’,3’-Dideoxy-5-fluoro-3’-thiacytidine in Rats
Abobo, C. V., Lan, N. I., Schinazi, R. F., Liotta, D. C., & Boudinot, F. D. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830122 · Cited by 13
Chang, M., Sood, V. K., Wilson, G. J., Kloosterman, D. A., Sanders, P. E., Hauer, M. J., & Fagerness, P. E. (1997) · PubMed · Cited by 13
Immunologic issues in anti-retroviral therapy
Yarchoan, R., Mitsuya, H., & Broder, S. E. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90128-v · Cited by 13
In Vitro Screening of Nucleoside Analog Combinations for Potential Use in Anti-HIV Therapy
Veal, G. J., Barry, M. G., Khoo, S. H., & Back, D. J. (1997) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1997.13.481 · Cited by 13
Hendrix, C. W., Flexner, C. W., Szebeni, J., Kuwahara, S. K., Pennypacker, S. D., Weinstein, J. N., & Lietman, P. S. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.5.1036 · Cited by 13
Gröschel, B., Cinátl, J., Périgaud, C., Gosselin, G., Imbach, J., Doerr, H. W., & Cinatl, J. (2002) · Antiviral Research · doi:10.1016/s0166-3542(01)00205-4 · Cited by 13
HIV-1 protease inhibitors in development
Catamancio, S. L. S., & Rusconi, S. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.3.387 · Cited by 13
Gao, Y., Katsuraya, K., Kaneko, Y., Mimura, T., Nakashima, H., & Uryu, T. (1998) · Polymer Journal · doi:10.1295/polymj.30.31 · Cited by 13
Tachedjian, G., French, M. A., & MILLS, J. S. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.3038 · Cited by 13
Palmer, S., & Cox, S. (1994) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029400500608 · Cited by 13
Taylor, D. L., Brennan, T., BRIDGES, C. G., Kang, M. S., & Tyms, A. S. (1995) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029500600303 · Cited by 13
Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects
Mulder, J. W., de Wolf, F., Goudsmit, J., Cload, P., Coutinho, R. A., Fiddian, A. P., Schellekens, P. T. A., van der Noordaa, J., & Lange, J. M. A. (1990) · Antiviral Research · doi:10.1016/0166-3542(90)90028-6 · Cited by 13
Nucleoside drug resistance in HIV-1 reverse transcriptase
Yadav, P. N., Yadav, J. S., & Modak, M. J. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0395-193 · Cited by 13
Ito, M., Baba, M., Shigeta, S., Clercq, E. D., Walker, R. T., Tanaka, H., & Miyasaka, T. (1991) · Antiviral Research · doi:10.1016/0166-3542(91)90013-h · Cited by 13
Lu, W., & Andrieu, J. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1014 · Cited by 13
Paul, S. M., & Jorden, V. S. B. (2003) · Cited by 13
Dimitrov, D. H., Hollinger, F. B., Baker, C. J., Kline, M. W., Doyle, M. D., Bremer, J. W., & Shearer, W. T. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.4.818 · Cited by 13
Cross-Resistance between AZT, ddl and other Antiretroviral Drugs in Primary Isolates of HIV-1
Cox, S. W., Aperia, K., Sandström, E., Holmberg, V., Morfeldt-Månson, L., Broström, C., Wahrén, B., & Albert, J. (1994) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029400500102 · Cited by 13
Efficacy of Combination Antiretroviral Therapy
Collier, A. C. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-9209-6_33 · Cited by 12
Stability analysis of mixtures of mutagenetic trees
Bogojeska, J., Lengauer, T., & Rahnenführer, J. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-165 · Cited by 12
Didanosine, a new antiretroviral drug: A review
Franssen, R. M. E., Meenhorst, P. L., Koks, C. H. W., & Beijnen, J. H. (1992) · Pharmacy World & Science · doi:10.1007/bf01977617 · Cited by 12
Li, H., Chang, S., Han, Y., Zhuang, D., Li, L., Liu, Y., Liu, S. M., Bao, Z., Zhang, W., Song, H., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1928-x · Cited by 12
Short Peptides with Induced β-Turn Inhibit the Interaction between HIV-1 gp120 and CD4
Choi, Y. H., Rho, W. S., Kim, N. D., Park, S. J., Shin, D. H., Kim, J.-W., Im, S. H., Won, H. S., Lee, C. W., Chae, C. B., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000403+ · Cited by 12
Orlando, P., Strazzullo, G., Carretta, F., Falco, M. D., & Grippo, P. (1996) · Cellular and Molecular Life Sciences · doi:10.1007/bf01923995 · Cited by 12
Morse, G. D., Lechner, J. L., Santora, J. A., & Rozek, S. L. (1990) · DICP · doi:10.1177/106002809002400720 · Cited by 12
Metadata
- Authors
- Larder, B. A., Darby, G., & Richman, D. D.
- Affiliations
- Wellcome Trust (GB)
- University of California San Diego (US)
- ORCID
- Richman, Douglas D.
- Venue
- Science
- Published
- 1989-03-31
- Volume
- 243
- Issue
- 4899
- Pages
- 1731-1734
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2086462809
- Cited by
- 1,559
- References
- 22
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 3 · 2023: 10 · 2022: 12 · 2021: 8 · 2020: 9 · 2019: 12 · 2018: 6 · 2017: 13 · 2016: 16 · 2015: 10 · 2014: 21 · 2013: 13 · 2012: 16
- FWCI
- 157.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HB-6-7019)
- National Institute of Allergy and Infectious Diseases (AI-62548, AI-52578)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- HIV drug resistance, zidovudine resistance, AIDS, AIDS-related complex, antiretroviral therapy, 2',3'-dideoxycytidine, phosphonoformate
- MeSH terms
- Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Drug Resistance, HeLa Cells, HIV, Humans, Microbial Sensitivity Tests, Phosphonoacetic Acid, Viral Plaque Assay, Retroviridae Proteins, Virus Replication, Zidovudine, Dideoxynucleosides, Zalcitabine, HIV Core Protein p24, Foscarnet, Reverse Transcriptase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.